{"id":17500,"date":"2026-01-23T15:23:30","date_gmt":"2026-01-23T20:23:30","guid":{"rendered":"https:\/\/eczemahelp.ca\/?p=17500"},"modified":"2026-02-17T15:28:09","modified_gmt":"2026-02-17T20:28:09","slug":"un-medecin-vous-parle-de-rinvoq-upadacitinib","status":"publish","type":"post","link":"https:\/\/eczemahelp.ca\/fr\/un-medecin-vous-parle-de-rinvoq-upadacitinib\/","title":{"rendered":"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib)"},"content":{"rendered":"<h2>Apprenez-en plus sur les inhibiteurs de JAK pour la voie orale contre la dermatite atopique avec la D<sup>re<\/sup> Ashley Sutherland, dermatologue<\/h2>\n<p><span style=\"font-weight: 400;\">La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma<\/span><span style=\"font-weight: 400;\"> a demand\u00e9 \u00e0 la D<\/span><span style=\"font-weight: 400;\"><sup>re <\/sup><\/span><span style=\"font-weight: 400;\">Ashley Sutherland (M.\u00a0Sc., FRCPC), dermatologue, <\/span><span style=\"font-weight: 400;\">de nous faire part de son expertise au sujet de <\/span><span style=\"font-weight: 400;\">Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> (upadacitinib), un inhibiteur de JAK, dans le traitement de la dermatite atopique (DA), soit la forme la plus courante d\u2019ecz\u00e9ma.<\/span><\/p>\n<h2>Que sont les inhibiteurs de JAK pour la voie orale?<\/h2>\n<p><span style=\"font-weight: 400;\">De nombreux patients atteints de DA parviennent \u00e0 ma\u00eetriser leur maladie \u00e0 l&rsquo;aide de traitements topiques prescrits et de modifications au mode de vie. Toutefois, chez certains patients, les traitements topiques peuvent ne pas suffire pour ma\u00eetriser la DA mod\u00e9r\u00e9e ou s\u00e9v\u00e8re, et un dermatologue peut envisager le recours \u00e0 un traitement \u00e0 action g\u00e9n\u00e9rale, comme un inhibiteur de JAK pris par voie orale. Un m\u00e9dicament avanc\u00e9 contre la DA peut entra\u00eener la disparition compl\u00e8te des l\u00e9sions et att\u00e9nuer consid\u00e9rablement les d\u00e9mangeaisons et les \u00e9ruptions cutan\u00e9es.<\/span><\/p>\n<h2>Comment Rinvoq\u00ae agit-il?<\/h2>\n<p><span style=\"font-weight: 400;\">Les inhibiteurs de JAK pour la voie orale traitent la DA en agissant sur les voies inflammatoires hyperactives \u00e0 l\u2019origine de l\u2019inflammation, entra\u00eenant des d\u00e9mangeaisons et des \u00e9ruptions cutan\u00e9es.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> cible de mani\u00e8re s\u00e9lective la JAK1, une prot\u00e9ine qui joue un r\u00f4le important dans les voies alimentant l\u2019inflammation et les d\u00e9mangeaisons associ\u00e9es \u00e0 la DA. Les inhibiteurs de JAK pour la voie orale calment les voies inflammatoires hyperactives, \u00e0 l\u2019origine des pouss\u00e9es de DA. Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> parvient \u00e0 att\u00e9nuer rapidement les d\u00e9mangeaisons et les sympt\u00f4mes cutan\u00e9s et procure un soulagement \u00e0 de nombreux patients<\/span><span style=\"font-weight: 400;\"><sup>1<\/sup><\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2>Comment Rinvoq\u00ae s&rsquo;administre-t-il?<\/h2>\n<p><span style=\"font-weight: 400;\">Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> est offert sous la forme d\u2019un comprim\u00e9 qui se prend une fois par jour par la bouche. Les doses employ\u00e9es dans le traitement de la DA sont de 15\u00a0mg et de 30\u00a0mg.<\/span><\/p>\n<h2>Qui peut prendre Rinvoq\u00ae?<\/h2>\n<p><span style=\"font-weight: 400;\">Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> est approuv\u00e9 pour le traitement des adultes et des adolescents \u00e2g\u00e9s de 12\u00a0ans ou plus atteints de dermatite atopique mod\u00e9r\u00e9e \u00e0 grave dont la maladie n\u2019a pas r\u00e9pondu \u00e0 d\u2019autres traitements et n\u2019est pas ma\u00eetris\u00e9e de fa\u00e7on ad\u00e9quate avec d\u2019autres traitements oraux ou injectables (dont les m\u00e9dicaments biologiques), ou lorsque ces traitements sont d\u00e9conseill\u00e9s<\/span><span style=\"font-weight: 400;\">. <\/span><span style=\"font-weight: 400;\">Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> peut \u00eatre utilis\u00e9 avec ou sans traitements m\u00e9dicamenteux topiques contre la dermatite atopique.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<h2>Quels sont les effets secondaires de ce m\u00e9dicament?<\/h2>\n<p><span style=\"font-weight: 400;\">Tous les m\u00e9dicaments sont associ\u00e9s \u00e0 des risques et \u00e0 des bienfaits qui doivent \u00eatre pass\u00e9s en revue avec le professionnel de la sant\u00e9 prescripteur. Ce m\u00e9dicament peut augmenter le risque d\u2019\u00e9v\u00e9nements peu fr\u00e9quents, mais graves, comme des caillots sanguins, des manifestations cardiaques, des cancers et certaines infections.<\/span> <span style=\"font-weight: 400;\">Les renseignements th\u00e9rapeutiques des inhibiteurs de JAK pour la voie orale d\u00e9livr\u00e9s sur ordonnance contiennent des mises en garde et pr\u00e9cautions (en encadr\u00e9 noir), en fonction des types d\u2019effets ind\u00e9sirables qui ont \u00e9t\u00e9 rapport\u00e9s. <\/span><span style=\"font-weight: 400;\">Si vous ou votre enfant pr\u00e9sentez ces effets secondaires ou avez la moindre pr\u00e9occupation au sujet de ce traitement, consultez le professionnel de la sant\u00e9 qui vous l\u2019a prescrit.<\/span><\/p>\n<h2>Que faire si ma dermatite atopique ne s\u2019att\u00e9nue pas?<\/h2>\n<p><span style=\"font-weight: 400;\">Si vous pensez que votre DA ne r\u00e9pond pas au traitement, informez-en votre m\u00e9decin. Il se peut que votre plan de traitement doive \u00eatre modifi\u00e9. Un professionnel de la sant\u00e9 qualifi\u00e9, comme un dermatologue, peut r\u00e9\u00e9valuer votre maladie ou celle de votre enfant et \u00e9ventuellement revoir le plan de traitement. Il n\u2019existe pas de traitement curatif de la DA, mais il y a d\u00e9sormais de nombreux traitements qui peuvent aider les patients.\u00a0<\/span><\/p>\n<p>La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma remercie la D<sup>re<\/sup> Ashley Sutherland (M. Sc., FRCPC) de sa contribution volontaire \u00e0 ce contenu \u00e9ducatif.<\/p>\n<p><span style=\"font-weight: 400;\"><strong>R\u00e9f\u00e9rence<\/strong> : <\/span><span style=\"font-weight: 400;\"><sup>1<\/sup> <\/span><span style=\"font-weight: 400;\">AbbVie (avril 2025). <\/span><a href=\"https:\/\/www.abbvie.ca\/content\/dam\/abbvie-dotcom\/ca\/fr\/documents\/products\/RINVOQ_PM_FR.pdf\"><span style=\"font-weight: 400;\">Monographie de Rinvoq<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><\/a><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.abbvie.ca\/content\/dam\/abbvie-dotcom\/ca\/fr\/documents\/products\/RINVOQ_PM_FR.pdf\"> (upadacitinib), comprim\u00e9s d\u2019upadacitinib \u00e0 lib\u00e9ration prolong\u00e9e (voie orale)<\/a>.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">Avis de non-responsabilit\u00e9\u00a0: L\u2019information contenue dans cette ressource ne remplace pas les conseils d\u2019un m\u00e9decin et ne doit pas servir d\u2019outil diagnostique. L\u2019information \u00e9tait \u00e0 jour \u00e0 la date de publication. Les interventions, les m\u00e9dicaments et les plans de traitement sont tous associ\u00e9s \u00e0 des risques et \u00e0 des bienfaits. Il est important de discuter de ses besoins particuliers ou de ceux de son enfant avec un professionnel de la sant\u00e9 qualifi\u00e9.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Apprenez-en plus sur les inhibiteurs de JAK pour la voie orale contre la dermatite atopique avec la Dre Ashley Sutherland, dermatologue La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la Dre Ashley Sutherland (M.\u00a0Sc., FRCPC), dermatologue, de nous faire part de son expertise au sujet de Rinvoq\u00ae (upadacitinib), un inhibiteur de JAK, dans le traitement [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53],"tags":[],"class_list":["post-17500","post","type-post","status-publish","format-standard","hentry","category-traitements"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib) | Eczema Society of Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib) | Eczema Society of Canada\" \/>\n<meta property=\"og:description\" content=\"Apprenez-en plus sur les inhibiteurs de JAK pour la voie orale contre la dermatite atopique avec la Dre Ashley Sutherland, dermatologue La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la Dre Ashley Sutherland (M.\u00a0Sc., FRCPC), dermatologue, de nous faire part de son expertise au sujet de Rinvoq\u00ae (upadacitinib), un inhibiteur de JAK, dans le traitement [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/\" \/>\n<meta property=\"og:site_name\" content=\"Eczema Society of Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EczemaSocietyofCanada\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-23T20:23:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-17T20:28:09+00:00\" \/>\n<meta name=\"author\" content=\"support@1dea.ca\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:site\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"support@1dea.ca\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/\"},\"author\":{\"name\":\"support@1dea.ca\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/person\\\/49d21625952d7bdf0988f82470cacc00\"},\"headline\":\"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib)\",\"datePublished\":\"2026-01-23T20:23:30+00:00\",\"dateModified\":\"2026-02-17T20:28:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/\"},\"wordCount\":765,\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"articleSection\":[\"Traitements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/\",\"name\":\"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib) | Eczema Society of Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\"},\"datePublished\":\"2026-01-23T20:23:30+00:00\",\"dateModified\":\"2026-02-17T20:28:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-rinvoq-upadacitinib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"name\":\"Eczema Society of Canada\",\"description\":\"Educational Resources\",\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eczemahelp.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\",\"name\":\"Eczema Society of Canada\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"width\":362,\"height\":360,\"caption\":\"Eczema Society of Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EczemaSocietyofCanada\",\"https:\\\/\\\/x.com\\\/EczemaSocietyCA\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/EczemaHelp\",\"https:\\\/\\\/www.instagram.com\\\/eczemasocietyofcanada\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/person\\\/49d21625952d7bdf0988f82470cacc00\",\"name\":\"support@1dea.ca\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502\",\"caption\":\"support@1dea.ca\"},\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/author\\\/support1dea-ca\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib) | Eczema Society of Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/","og_locale":"fr_FR","og_type":"article","og_title":"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib) | Eczema Society of Canada","og_description":"Apprenez-en plus sur les inhibiteurs de JAK pour la voie orale contre la dermatite atopique avec la Dre Ashley Sutherland, dermatologue La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la Dre Ashley Sutherland (M.\u00a0Sc., FRCPC), dermatologue, de nous faire part de son expertise au sujet de Rinvoq\u00ae (upadacitinib), un inhibiteur de JAK, dans le traitement [&hellip;]","og_url":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/","og_site_name":"Eczema Society of Canada","article_publisher":"https:\/\/www.facebook.com\/EczemaSocietyofCanada","article_published_time":"2026-01-23T20:23:30+00:00","article_modified_time":"2026-02-17T20:28:09+00:00","author":"support@1dea.ca","twitter_card":"summary_large_image","twitter_creator":"@EczemaSocietyCA","twitter_site":"@EczemaSocietyCA","twitter_misc":{"\u00c9crit par":"support@1dea.ca","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/#article","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/"},"author":{"name":"support@1dea.ca","@id":"https:\/\/eczemahelp.ca\/#\/schema\/person\/49d21625952d7bdf0988f82470cacc00"},"headline":"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib)","datePublished":"2026-01-23T20:23:30+00:00","dateModified":"2026-02-17T20:28:09+00:00","mainEntityOfPage":{"@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/"},"wordCount":765,"publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"articleSection":["Traitements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/","url":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/","name":"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib) | Eczema Society of Canada","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/#website"},"datePublished":"2026-01-23T20:23:30+00:00","dateModified":"2026-02-17T20:28:09+00:00","breadcrumb":{"@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-rinvoq-upadacitinib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eczemahelp.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Un m\u00e9decin vous parle de Rinvoq\u00ae (upadacitinib)"}]},{"@type":"WebSite","@id":"https:\/\/eczemahelp.ca\/#website","url":"https:\/\/eczemahelp.ca\/","name":"Eczema Society of Canada","description":"Educational Resources","publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eczemahelp.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/eczemahelp.ca\/#organization","name":"Eczema Society of Canada","url":"https:\/\/eczemahelp.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/","url":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","width":362,"height":360,"caption":"Eczema Society of Canada"},"image":{"@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EczemaSocietyofCanada","https:\/\/x.com\/EczemaSocietyCA","https:\/\/www.youtube.com\/user\/EczemaHelp","https:\/\/www.instagram.com\/eczemasocietyofcanada\/"]},{"@type":"Person","@id":"https:\/\/eczemahelp.ca\/#\/schema\/person\/49d21625952d7bdf0988f82470cacc00","name":"support@1dea.ca","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502","url":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502","caption":"support@1dea.ca"},"url":"https:\/\/eczemahelp.ca\/fr\/author\/support1dea-ca\/"}]}},"_links":{"self":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/17500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/comments?post=17500"}],"version-history":[{"count":3,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/17500\/revisions"}],"predecessor-version":[{"id":18822,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/17500\/revisions\/18822"}],"wp:attachment":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/media?parent=17500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/categories?post=17500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/tags?post=17500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}